UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022823
Receipt number R000026305
Scientific Title A study to evaluate the inhibitory effect of Chrysanthemum Morifolium Flower Extract containing supplement on diet-induced serum uric acid elevation in healthy male subjects
Date of disclosure of the study information 2016/07/30
Last modified on 2016/08/29 14:37:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to evaluate the inhibitory effect of Chrysanthemum Morifolium Flower Extract containing supplement on diet-induced serum uric acid elevation in healthy male subjects

Acronym

A study to evaluate the inhibitory effect of Chrysanthemum Morifolium Flower Extract containing supplement on serum uric acid

Scientific Title

A study to evaluate the inhibitory effect of Chrysanthemum Morifolium Flower Extract containing supplement on diet-induced serum uric acid elevation in healthy male subjects

Scientific Title:Acronym

A study to evaluate the inhibitory effect of Chrysanthemum Morifolium Flower Extract containing supplement on serum uric acid

Region

Japan


Condition

Condition

Healthy male volunteers, mild hyperuricemia

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the inhibitory effect of Chrysanthemum Morifolium Flower Extract containing supplement on serum uric acid

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Serum uric acid level

Key secondary outcomes

Urine uric acid level


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Chrysanthemum Morifolium Flower containing supplement

Interventions/Control_2

Chrysanthemum Morifolium Flower non-containing supplement

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male

Key inclusion criteria

Serum uric acid 5.5-8.0 mg/dL

Key exclusion criteria

1) Taking anti-hyperuricemic drugs
2) History of gouty arthritis, gouty node, and/or gouty attack
3) Taking drugs or functional food that may affect serum uric acid level
4) Participation in any clinical trial within 90 days of the commencement of the trial

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Shimoda

Organization

Oryza Oil & Fat Chemical Co., LTD.

Division name

Food Development Dept., R & D Center

Zip code


Address

1 Numata Kitagata Kitagata-cho, Ichinomiya City,Aichi Pref.

TEL

0586-86-5141

Email

kaihatsu@mri.biglobe.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shoketsu Hitoe

Organization

Oryza Oil & Fat Chemical Co., LTD.

Division name

Food Development Dept., R & D Center

Zip code


Address

1 Numata Kitagata Kitagata-cho, Ichinomiya City,Aichi Pref.

TEL

0586-86-5141

Homepage URL


Email

kaihatsu@mri.biglobe.ne.jp


Sponsor or person

Institute

Oryza Oil & Fat Chemical Co., LTD.

Institute

Department

Personal name



Funding Source

Organization

Food Development Dept., R & D Center

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 05 Month 11 Day

Date of IRB


Anticipated trial start date

2016 Year 06 Month 23 Day

Last follow-up date

2016 Year 07 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 06 Month 21 Day

Last modified on

2016 Year 08 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026305


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name